V011-1235 Screening compound: 2,6-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline-5-carbonyl]morpholine

V011-1235 Screening compound: 2,6-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline-5-carbonyl]morpholine
V011-1235 Screening compound: 2,6-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline-5-carbonyl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-1235
2,6-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline-5-carbonyl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-1235

Molecular Formula

C28H34F3N3O3 (C28 H34 F3 N3 O3)

Compound Name

2,6-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline-5-carbonyl]morpholine

IUPAC name

26-dimethyl-4-[3-(2-phenoxyethyl)-8-(trifluoromethyl)-1H2H3H4H4aH5H6H-pyrazino[12-a]quinoline-5-carbonyl]morpholine

SMILES

CC(C1)OC(C)CN1C(C(C1)C(CN(CCOc2ccccc2)CC2)N2c2c1cc(C(F)(F)F)cc2)=O

InChI

InChI=1S/C28H34F3N3O3/c1-19-16-33(17-20(2)37-19)27(35)24-15-21-14-22(28(29,30)31)8-9-25(21)34-11-10-32(18-26(24)34)12-13-36-23-6-4-3-5-7-23/h3-9,14,19-20,24,26H,10-13,15-18H2,1-2H3

InChI Key

FOOAQQLGYDPMKP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19853386

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.269

Distribution Coefficient, logD

3.559

Water Solubility, LogSw

-4.22

Polar Surface Area

37.060

Acid Dissociation Constant (pKa)

22.94

Base Dissociation Constant (pKb)

8.02

Number of Chiral Centers

4.00

Percent sp3 carbon bonding

53.60

V011-1235 in Drug Discovery

Included in Screening Libraries

Bromodomain Modulators Library (5801 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V011-1235 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-1235?
Check Price and Availability of V011-1235, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-1235 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-1235
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-1235
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-1235 available by request